BioSpace News Archive

The Neurology Center has made available three-month results of their randomized controlled investigation of intravenously administering NuPlasma® young blood plasma into nineteen Parkinson’s disease patients.

New study from Blue Cross Blue Shield Association raises concerns about millennials’ long-term physical and mental health [24-April-2019] BOSTON , April 24, 2019 /PRNewswire/ -- Older millennials in Massachusetts are more likely than their peers across the country to have behavioral health conditions, according to the latest Health of America report from the Blue Cr

Groundwork BioAg, Ltd. is pleased to announce the 4/20 product launch of DYNAMYC™ premium mycorrhizal inoculants, uniquely formulated for cannabis cultivation.

New 150kV superficial treatment system spotlighted on Xstrahl booth (No. 3420) at ESTRO show in Milan, Italy, April 26th-29th

Eyecarrot Innovations Corp is pleased to announce that Binovi™ will be distributed throughout India in association with Dr.

Vectra research highlights precarious security risks in the healthcare industry due to legacy infrastructures and unmanaged devices

Over 1 billion serial numbers commissioned in Q1

Pooled safety and efficacy data for DEXENZA for the treatment of ocular pain and inflammation after ophthalmic surgery

Sensus Healthcare, Inc. (NASDAQ: SRTS), today announced that the Company has signed a research and development agreement with the Perelman School of Medicine at the University of Pennsylvania to collaborate with the radiation oncology department on clinical research and development for Sensus’ Sculptura

The 20-acre site will significantly expand Kite’s ability to manufacture a variety of chimeric antigen receptor T (CAR T) therapies